| dc.contributor.author | O'Driscoll, Lorraine | en |
| dc.date.accessioned | 2016-07-19T10:20:58Z | |
| dc.date.available | 2016-07-19T10:20:58Z | |
| dc.date.issued | 2013 | en |
| dc.date.submitted | 2013 | en |
| dc.identifier.citation | Breslin S, Corcoran C, Rani S, Crown J, O?Driscoll L., Assessment of neratinib-resistance and cross-resistance in HER2-overexpressing breast cancer cells., J. Clin. Oncol., 31, 15, 2013, 11520 - 11521 | en |
| dc.identifier.other | Y | en |
| dc.identifier.uri | http://hdl.handle.net/2262/76719 | |
| dc.description | PUBLISHED | en |
| dc.format.extent | 11520 | en |
| dc.format.extent | 11521 | en |
| dc.language.iso | en | en |
| dc.relation.ispartofseries | 31 | en |
| dc.relation.ispartofseries | 15 | en |
| dc.rights | Y | en |
| dc.title | Assessment of neratinib-resistance and cross-resistance in HER2-overexpressing breast cancer cells. | en |
| dc.title.alternative | J. Clin. Oncol. | en |
| dc.type | Published Abstract | en |
| dc.type.supercollection | scholarly_publications | en |
| dc.type.supercollection | refereed_publications | en |
| dc.identifier.peoplefinderurl | http://people.tcd.ie/lodrisc | en |
| dc.identifier.rssinternalid | 100736 | en |
| dc.rights.ecaccessrights | openAccess | |
| dc.subject.TCDTheme | Cancer | en |
| dc.identifier.rssuri | http://meetinglibrary.asco.org/content/116519-132 | en |
| dc.identifier.orcid_id | 0000-0002-9860-8262 | en |
